TAB

Welcome to the Brand page for “TAB”, which is offered here for Pharmaceuticals, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system;chemicals for use in the manufacture of drugs in the fields of drug performance and drug delivery for the biotechnical, biomedical, and pharmaceutical industries; and chemical preparations for medical, scientific, and manufacturing research use in the fields of drug performance and drug delivery for the biotechnical, and biomedical, and pharmaceutical industries;research services, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields;.

Its status is currently believed to be active. Its class is unavailable. “TAB” is believed to be currently owned by “Carigent Therapeutics, Inc.”